TKR |
Tyrosine kinase receptor |
SARS-CoV |
Severe acute respiratory syndrome coronavirus |
MERS-CoV |
Middle East respiratory syndrome coronavirus |
ACE2 |
Angiotensin conversion enzyme 2 |
RBD |
Receptor-binding domain |
HR |
Heptane repeats |
PRRs |
Pattern recognition receptors |
PAMP |
Pathogen-associated molecular patterns |
TLR |
Toll-like receptor |
RLR-RIG |
I-like receptor |
NLR-NOD |
Like receptor |
CLmin-C |
Type lectin-like receptors |
MDA5 |
Cytosolic receptor melanoma differentiation-associated gene 5 |
cGAS |
Nucleotidyltransferase cyclic GMP-AMP synthase |
NF-κB |
Transcription factor nuclear factor-κB |
IRF3 |
Interferon regulatory factor 3 |
IFN |
Interferon |
GFR |
Growth factor receptors |
EGFR |
Epithelial growth factor receptor |
NSCLC |
Non-small-cell lung cancer |
HMCV |
Human cytomegalovirus |
TKI |
Tyrosine kinase inhibitors |
PI3K |
Phosphoinositide 3 kinase |
TGEV |
Transmissible gastroenteritis virus |
FGFR |
Fibroblast growth factor receptor |
EBV |
Epstein–Barr virus |
NPC |
Non-keratinizing nasopharyngeal cancer |
PDGFR |
Platelet-derived growth factor receptors |
BTK |
Bruton tyrosine kinase |
SINE |
Selective inhibitor of nuclear export |
MHCV |
Mouse hepatitis coronavirus |
CEACAM1a |
Carcinoembryonic antigen-related cell adhesion molecule 1 |
JAKi |
JAK inhibitors |
BBB |
Blood–brain barrier |